News

August 26, 2025 ACC Press Release - Fungitell® is awarded FDA Breakthrough Device Designation for testing of Cerebrospinal Fluid (CSF) matrix as an aid in the diagnosis of Central Nervous System (CNS) fungal infection - For Immediate Release

August 6, 2024 ACC Press Release - With U.S. Pharmacopeia’s Approval of Chapter <86>, ACC is Positioned to Help More Biotech Companies Reduce Supply Chain Risk and Achieve Sustainability Goals - For Immediate Release

May 10, 2024 ACC Press Release - Associates of Cape Cod, Inc. (ACC) Marks 50 Years of Protection Through Detection with a New Look - For Immediate Release

November 16, 2021 ACC Press Release - Associates of Cape Cod, Inc., Recipient of the Pharma Manufacturing 2021 Innovation Award for its PyroSmart NextGen™ recombinant BET reagent - For Immediate Release

November 3, 2021 ACC Press Release - Associates of Cape Cod, Inc. Announces the Release of its One Millionth Horseshoe Crab From its Species Sustainability Project - For Immediate Release

April 23, 2021 ACC Press Release - Associates of Cape Cod, Inc. Announces Launch of PyroSmart NextGen™ Recombinant LAL Reagent - For Immediate Release

April 22, 2021 Article - COVID-19 and the Sustainability of the LAL Supply - PDA Letter

July 31, 2020 ACC Press Release - Introducing Fungitell STAT™ a single sample test used in the diagnosis of Invasive Fungal Infections. - For Immediate Release

June 15, 2020 - Horseshoe crabs may be the answer to a safe coronavirus vaccine next year. Here's why. - Doug Fraser, Cape Cod Times

June 12, 2020 - Horseshoe crab blood could be key to COVID-19 vaccine, expert says - Fox News

We Value Your Privacy
We use cookies to help give you the best experience on our site and to allow us and third parties to customize the marketing content you see across websites and social media. For more information see our Cookie Policy. Please be advised that Associates of Cape Cod, Inc. (ACC) has updated its Privacy Policy.